Finding accredited CPD
Influenza epidemics are associated with a significant increase in cardiovascular deaths.
A link between influenza infection and cardiovascular morbidity has been known for almost a century and more recent research quantifies the cardioprotective properties of influenza vaccination:
Cardiologists strongly encourage adherence to anticoagulants and heart failure medication and understand the critical importance of smoking cessation – but is the same emphasis applied to influenza vaccination, when the relative benefits approximate those of statins?
Fewer than 50% of those under 65 years of age with cardiac disease receive the influenza immunisation and many cardiac patients perceive the flu to be a nuisance rather than a credible threat to their cardiac and overall health.
Given its demonstrable cardiac protection and considering the risk profile of cardiology patients, cardiologists have a central role in recommending flu vaccination in partnership with general practitioners.
This educational activity has been designed to arm cardiologists with the knowledge to discuss the benefits of influenza immunisation and to consider recommending or referring their patients for vaccination.
Sponsored: This activity is sponsored by Sanofi.
Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.
Upon completion, your CPD activity record may take up to 48 hours to be reflected on your CPD Home Dashboard.
You have to log in to see the content of this module.
Provided by
Accredited by